Atlas Trials

Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic Events

Clinical trial NCT01675076 · COMPLETED

Trial details

NCT number
NCT01675076
Sponsor
Ottawa Heart Institute Research Corporation
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hematoma
Start date
2013-01-01
Primary completion
2017-10-01
Enrollment
663

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.